AI assistant
Sending…
SYNOPSYS INC — Director's Dealing 2014
Mar 5, 2014
29855_dirs_2014-03-05_b75555a6-5b0e-433c-b22d-4fb53ddc3d1c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNOPSYS INC (SNPS)
CIK: 0000883241
Period of Report: 2014-03-04
Reporting Person: SCHWARZ JOHN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-04 | Common Stock | M | 30000.0 | $26.73 | Acquired | 59859 | Direct |
| 2014-03-04 | Common Stock | S | 30000.0 | $40.3637 | Disposed | 29859 | Direct |
| 2014-03-04 | Common Stock | M | 10751.0 | $26.73 | Acquired | 40610 | Direct |
| 2014-03-04 | Common Stock | S | 10751.0 | $40.3637 | Disposed | 29859 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-04 | Non-Qualified Stock Option (right to buy) | $26.73 | M | 30000.0 | Disposed | 2014-05-30 | Common Stock (30000) | Direct |
| 2014-03-04 | Non-Qualified Stock Option (right to buy) | $26.73 | M | 10751.0 | Disposed | 2014-05-30 | Common Stock (10751) | Direct |
Footnotes
F1: The average price of $40.3637 consists of:[email protected],
[email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected],
[email protected], [email protected], [email protected], [email protected],
[email protected], [email protected], [email protected], [email protected],
[email protected], [email protected].
More from SYNOPSYS INC
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2